本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kiniksa Pharmaceuticals Ltd.

77.62
+2.473.29%
盤後77.750.1300+0.17%17:12 EDT
成交量:55.39萬
成交額:4,269.58萬
市值:60.56億
市盈率:78.40
高:77.64
開:75.06
低:74.91
收:75.15
52周最高:82.94
52周最低:35.20
股本:7,802.40萬
流通股本:3,994.15萬
量比:1.00
換手率:1.39%
股息:- -
股息率:- -
每股收益(TTM):0.9900
每股收益(LYR):0.7500
淨資產收益率:14.04%
總資產收益率:8.05%
市淨率:9.26
市盈率(LYR):103.49

資料載入中...

2024/06/28

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/28

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/28

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/28

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/28

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/25

重要事件披露

Form 8-K - Current report
2024/06/14

重要事件披露

Form 8-K - Current report
2024/06/05

重要事件披露

Form 8-K - Current report
2024/04/25

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/23

重要事件披露

Form 8-K - Current report
2024/04/02

重要事件披露

Form 8-K - Current report
2024/03/29

重要事件披露

Form 8-K - Current report
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/28

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]